NewLeaf Symbiotics Funding & Investors
St. Louis, MO
NewLeaf Symbiotics, Inc. operates as an agricultural biotech company. The Company develops and commercializes a family of beneficial bacteria known as PPFMs (Pink Pigmented Facultative Methylotrophs) which are ubiquitous in nature and improve plant health, promote early growth, and increase crop yield. NewLeaf markets its products throughout the United States.
newleafsym.comTotal Amount Raised: $132,551,080
NewLeaf Symbiotics Funding Rounds
Series D
$45,000,000
Series D Investors
Gullspång Re:foodLeaps by BayerOtter CapitalS2G VenturesConvertible Note
$10,000,000
Series D
$20,000,000
Series D Investors
RockPort CapitalOtter CapitalLeaps by BayerKoch Agronomic ServicesS2G VenturesSeries C
$30,000,000
Series C Investors
Monsanto Growth Ventures (MGV)Otter CapitalRockPort CapitalPangaea Ventures USOpen Prairie VenturesS2G VenturesLewis & Clark VenturesLeaps by BayerDebt Financing
$3,551,078
Series B
$17,000,000
Series B Investors
Open Prairie VenturesPalo Alto InvestorsRockPort CapitalPangaea Ventures USSeries A
$7,000,000
Series A Investors
Open Prairie VenturesPangaea Ventures USRockPort Capital
Funding info provided by Diffbot.